Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

To Go or Stay: The Development, Benefit, and Detriment of Tissue-Resident Memory CD8 T Cells during Central Nervous System Viral Infections.

Mockus TE, Ren HM; Shwetank, Lukacher AE.

Viruses. 2019 Sep 11;11(9). pii: E842. doi: 10.3390/v11090842. Review.

2.

PD-1 Dynamically Regulates Inflammation and Development of Brain-Resident Memory CD8 T Cells During Persistent Viral Encephalitis.

Shwetank, Frost EL, Mockus TE, Ren HM, Toprak M, Lauver MD, Netherby-Winslow CS, Jin G, Cosby JM, Evavold BD, Lukacher AE.

Front Immunol. 2019 Apr 17;10:783. doi: 10.3389/fimmu.2019.00783. eCollection 2019.

3.

CD4 T cells control development and maintenance of brain-resident CD8 T cells during polyomavirus infection.

Mockus TE, Shwetank, Lauver MD, Ren HM, Netherby CS, Salameh T, Kawasawa YI, Yue F, Broach JR, Lukacher AE.

PLoS Pathog. 2018 Oct 29;14(10):e1007365. doi: 10.1371/journal.ppat.1007365. eCollection 2018 Oct.

4.

Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors.

Ward-Kavanagh LK, Kokolus KM, Cooper TK, Lukacher AE, Schell TD.

Cancer Immunol Immunother. 2018 Apr;67(4):639-652. doi: 10.1007/s00262-018-2115-2. Epub 2018 Jan 13.

5.

Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo.

Maru S, Jin G, Desai D, Amin S, Shwetank, Lauver MD, Lukacher AE.

mSphere. 2017 Nov 15;2(6). pii: e00494-17. doi: 10.1128/mSphereDirect.00494-17. eCollection 2017 Nov-Dec.

6.

Maintenance of PD-1 on brain-resident memory CD8 T cells is antigen independent.

Shwetank, Abdelsamed HA, Frost EL, Schmitz HM, Mockus TE, Youngblood BA, Lukacher AE.

Immunol Cell Biol. 2017 Nov;95(10):953-959. doi: 10.1038/icb.2017.62. Epub 2017 Aug 22.

7.

Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury.

Kim SC, Wang J, Dong Y, Mathews DV, Albrecht JA, Breeden CP, Farris AB, Lukacher AE, Ford ML, Newell KA, Adams AB.

Transplant Direct. 2017 May 12;3(6):e161. doi: 10.1097/TXD.0000000000000677. eCollection 2017 Jun.

8.

TCR stimulation strength is inversely associated with establishment of functional brain-resident memory CD8 T cells during persistent viral infection.

Maru S, Jin G, Schell TD, Lukacher AE.

PLoS Pathog. 2017 Apr 14;13(4):e1006318. doi: 10.1371/journal.ppat.1006318. eCollection 2017 Apr.

9.

Reducing persistent polyomavirus infection increases functionality of virus-specific memory CD8 T cells.

Qin Q, Lauver M, Maru S, Lin E, Lukacher AE.

Virology. 2017 Feb;502:198-205. doi: 10.1016/j.virol.2016.12.028. Epub 2017 Jan 5.

10.

Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.

Qin Q, Shwetank, Frost EL, Maru S, Lukacher AE.

J Virol. 2016 Apr 29;90(10):5187-99. doi: 10.1128/JVI.00199-16. Print 2016 May 15.

11.

Cutting Edge: Resident Memory CD8 T Cells Express High-Affinity TCRs.

Frost EL, Kersh AE, Evavold BD, Lukacher AE.

J Immunol. 2015 Oct 15;195(8):3520-4. doi: 10.4049/jimmunol.1501521. Epub 2015 Sep 14.

12.

Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy.

Badell IR, Kitchens WH, Wagener ME, Lukacher AE, Larsen CP, Ford ML.

Am J Transplant. 2015 Dec;15(12):3081-94. doi: 10.1111/ajt.13399. Epub 2015 Jul 30.

13.

Distinct and synergistic roles of FcγRIIB deficiency and 129 strain-derived SLAM family proteins in the development of spontaneous germinal centers and autoimmunity.

Soni C, Domeier PP, Wong EB, Shwetank, Khan TN, Elias MJ, Schell SL, Lukacher AE, Cooper TK, Rahman ZS.

J Autoimmun. 2015 Sep;63:31-46. doi: 10.1016/j.jaut.2015.06.011. Epub 2015 Jul 7.

14.

The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy.

Frost EL, Lukacher AE.

Front Immunol. 2015 Jan 5;5:646. doi: 10.3389/fimmu.2014.00646. eCollection 2014. Review.

15.

Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.

Hofstetter AR, Evavold BD, Lukacher AE.

Viral Immunol. 2013 Feb;26(1):109-13. doi: 10.1089/vim.2012.0052. Epub 2013 Feb 1.

16.

CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustion.

Wilson JJ, Pack CD, Lin E, Frost EL, Albrecht JA, Hadley A, Hofstetter AR, Tevethia SS, Schell TD, Lukacher AE.

J Immunol. 2012 May 1;188(9):4340-8. doi: 10.4049/jimmunol.1103727. Epub 2012 Mar 23.

17.

Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice.

Albrecht JA, Dong Y, Wang J, Breeden C, Farris AB 3rd, Lukacher AE, Newell KA.

Am J Transplant. 2012 Jun;12(6):1419-28. doi: 10.1111/j.1600-6143.2012.04005.x. Epub 2012 Mar 15.

18.

MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection.

Hofstetter AR, Ford ML, Sullivan LC, Wilson JJ, Hadley A, Brooks AG, Lukacher AE.

J Immunol. 2012 Apr 1;188(7):3071-9. doi: 10.4049/jimmunol.1103554. Epub 2012 Mar 5.

19.

The carboxypeptidase ACE shapes the MHC class I peptide repertoire.

Shen XZ, Billet S, Lin C, Okwan-Duodu D, Chen X, Lukacher AE, Bernstein KE.

Nat Immunol. 2011 Oct 2;12(11):1078-85. doi: 10.1038/ni.2107.

20.

Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function.

Desmarets M, Mylvaganam G, Waller EK, Josephson CD, Pack C, Lukacher AE, Zimring JC.

Am J Transplant. 2011 Sep;11(9):1825-34. doi: 10.1111/j.1600-6143.2011.03730.x.

21.

Gamma interferon controls mouse polyomavirus infection in vivo.

Wilson JJ, Lin E, Pack CD, Frost EL, Hadley A, Swimm AI, Wang J, Dong Y, Breeden CP, Kalman D, Newell KA, Lukacher AE.

J Virol. 2011 Oct;85(19):10126-34. doi: 10.1128/JVI.00761-11. Epub 2011 Jul 20.

22.

Some unmet challenges in the immunology of viral infections.

Rouse BT, Lukacher AE.

Discov Med. 2010 Oct;10(53):363-70. Review.

23.

Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.

Hofstetter AR, Sullivan LC, Lukacher AE, Brooks AG.

Curr Opin Immunol. 2011 Feb;23(1):104-10. doi: 10.1016/j.coi.2010.09.009. Epub 2010 Oct 21. Review.

24.

Heterogeneity among viral antigen-specific CD4+ T cells and their de novo recruitment during persistent polyomavirus infection.

Lin E, Kemball CC, Hadley A, Wilson JJ, Hofstetter AR, Pack CD, Lukacher AE.

J Immunol. 2010 Aug 1;185(3):1692-700. doi: 10.4049/jimmunol.0904210. Epub 2010 Jul 9.

25.

Persistence of viral infection despite similar killing efficacy of antiviral CD8(+) T cells during acute and chronic phases of infection.

Ganusov VV, Lukacher AE, Byers AM.

Virology. 2010 Sep 15;405(1):193-200. doi: 10.1016/j.virol.2010.05.029. Epub 2010 Jun 26.

26.

Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus.

Swimm AI, Bornmann W, Jiang M, Imperiale MJ, Lukacher AE, Kalman D.

J Virol. 2010 May;84(9):4243-51. doi: 10.1128/JVI.00129-10. Epub 2010 Feb 24.

27.

Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope.

Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC.

Blood. 2010 May 13;115(19):3989-96. doi: 10.1182/blood-2009-08-238568. Epub 2010 Jan 19.

28.

Immunity to polyomavirus infection: the polyomavirus-mouse model.

Swanson PA 2nd, Lukacher AE, Szomolanyi-Tsuda E.

Semin Cancer Biol. 2009 Aug;19(4):244-51. doi: 10.1016/j.semcancer.2009.02.003. Epub 2009 Feb 14. Review.

29.

Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection.

Swanson PA 2nd, Hofstetter AR, Wilson JJ, Lukacher AE.

J Immunol. 2009 May 1;182(9):5198-202. doi: 10.4049/jimmunol.0900421.

30.

Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection.

Sullivan CS, Sung CK, Pack CD, Grundhoff A, Lukacher AE, Benjamin TL, Ganem D.

Virology. 2009 Apr 25;387(1):157-67. doi: 10.1016/j.virol.2009.02.017. Epub 2009 Mar 9.

31.

An MHC class Ib-restricted CD8 T cell response confers antiviral immunity.

Swanson PA 2nd, Pack CD, Hadley A, Wang CR, Stroynowski I, Jensen PE, Lukacher AE.

J Exp Med. 2008 Jul 7;205(7):1647-57. doi: 10.1084/jem.20080570. Epub 2008 Jun 9.

32.

Generation of antiviral major histocompatibility complex class I-restricted T cells in the absence of CD8 coreceptors.

Andrews NP, Pack CD, Lukacher AE.

J Virol. 2008 May;82(10):4697-705. doi: 10.1128/JVI.02698-07. Epub 2008 Mar 12.

33.

Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors.

Shen XZ, Lukacher AE, Billet S, Williams IR, Bernstein KE.

J Biol Chem. 2008 Apr 11;283(15):9957-65. doi: 10.1074/jbc.M709574200. Epub 2008 Feb 5.

34.

Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Kemball CC, Szomolanyi-Tsuda E, Lukacher AE.

J Virol. 2007 Dec;81(24):13743-53. Epub 2007 Oct 3.

35.

The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection.

Kemball CC, Pack CD, Guay HM, Li ZN, Steinhauer DA, Szomolanyi-Tsuda E, Lukacher AE.

J Immunol. 2007 Jul 15;179(2):1113-21.

36.

Early virus-associated bystander events affect the fitness of the CD8 T cell response to persistent virus infection.

Andrews NP, Pack CD, Vezys V, Barber GN, Lukacher AE.

J Immunol. 2007 Jun 1;178(11):7267-75.

37.

Protection against polyoma virus-induced tumors is perforin-independent.

Byers AM, Hadley A, Lukacher AE.

Virology. 2007 Feb 20;358(2):485-92. Epub 2006 Sep 28.

38.

Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

Vezys V, Masopust D, Kemball CC, Barber DL, O'Mara LA, Larsen CP, Pearson TC, Ahmed R, Lukacher AE.

J Exp Med. 2006 Oct 2;203(10):2263-9. Epub 2006 Sep 11.

39.
40.

A mouse model for polyomavirus-associated nephropathy of kidney transplants.

Han Lee ED, Kemball CC, Wang J, Dong Y, Stapler DC Jr, Hamby KM, Gangappa S, Newell KA, Pearson TC, Lukacher AE, Larsen CP.

Am J Transplant. 2006 May;6(5 Pt 1):913-22.

41.

Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.

Kemball CC, Lee ED, Szomolanyi-Tsuda E, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2006 Feb 1;176(3):1814-24.

42.

A cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets.

Kumar S, Skeen MJ, Adiri Y, Yoon H, Vezys VD, Lukacher AE, Evavold BD, Ziegler HK, Boss JM.

Cell Immunol. 2005 Oct;237(2):131-40. Epub 2006 Jan 10.

PMID:
16405934
43.

Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.

Kemball CC, Lee ED, Vezys V, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2005 Jun 15;174(12):7950-60.

44.

Pathogen-host standoff: immunity to polyomavirus infection and neoplasia.

Lukacher AE.

Immunol Res. 2004;29(1-3):139-50. Review.

PMID:
15181277
45.

Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.

Byers AM, Kemball CC, Moser JM, Lukacher AE.

J Immunol. 2003 Jul 1;171(1):17-21.

46.

Regulation of antiviral CD8+ T cells by inhibitory natural killer cell receptors.

Byers AM, Kemball CC, Andrews NP, Lukacher AE.

Microbes Infect. 2003 Feb;5(2):169-77. Review.

PMID:
12650775
47.

Memory CD8+ T cells provide an early source of IFN-gamma.

Kambayashi T, Assarsson E, Lukacher AE, Ljunggren HG, Jensen PE.

J Immunol. 2003 Mar 1;170(5):2399-408.

48.

IFN-gamma suspends the killing license of anti-tumor CTLs.

Lukacher AE.

J Clin Invest. 2002 Nov;110(10):1407-9. Review. No abstract available.

49.

Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.

Shirasugi N, Adams AB, Durham MM, Lukacher AE, Xu H, Rees P, Cowan SR, Williams MA, Pearson TC, Larsen CP.

J Immunol. 2002 Sep 1;169(5):2677-84.

50.

NK cell receptors in antiviral immunity.

Moser JM, Byers AM, Lukacher AE.

Curr Opin Immunol. 2002 Aug;14(4):509-16. Review.

PMID:
12088687

Supplemental Content

Loading ...
Support Center